Elevated expression and activity of key platelet receptors such as GPVI have been demonstrated in acute coronary syndromes17and ischemic stroke,14, 18with studies reporting higher GPVI expression with poorer clinical outcomes,19explaining the abundance of work being performed investigating its inhibition as a potential mechanism to reduce thrombosis. The gene discussed is GP6; the disease is ischemic stroke.